Reven Pharmaceuticals, Inc. — Form D/A
Reven Pharmaceuticals, Inc. of SARASOTA, FL, a company, filed a Form D amendment with the SEC on 2015-02-18. The offering totals $7.0M, of which $4.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-02-18
- Form: D/A
- Accession: 0000897069-15-000162
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $4.4M
- Remaining: $2.6M
- Minimum investment: $50K
- Investors: 48
- Date of first sale: 2014-01-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-212162
Issuer
- Name: Reven Pharmaceuticals, Inc.
- CIK: 0001556231
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Address: 4411 BEE RIDGE ROAD, SARASOTA, FL, 34233
- Phone: 941-320-9271
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Brian B Denomme | Director | Sarasota, FL |
| Peter B Lange | Director | Sarasota, FL |
| Brian B Denomme | Executive Officer | Sarasota, FL |
| Michael B Handley | Executive Officer | Sarasota, FL |
| Peter B Lange | Executive Officer | Sarasota, FL |
| Michael A Volk | Executive Officer | Sarasota, FL |
Other filings by this issuer (5)
More